A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

People with bipolar disorder face stigma and treatment challenges. Despite these barriers, it's possible to live a full and ...

Many people with depression and anxiety in the U.S. could benefit from medication but do not receive any treatment, psychiatrist Mark Olfson told Newsweek.

Despite conflicting data regarding the pharmacological management of Borderline Personality Disorder (BPD), a recent ...

Bipolar II Hypomania (4 days) One or more episodes required (2 weeks) Completed suicide in 10% to 15%, school/occupational failure, divorce Substance abuse or dependence, anorexia nervosa ...

Nintendo finally unveils the Switch 2 console confirming features like magnetic Joy-Cons and an optical sensor. The official trailer also confirms backward compatibility with Switch games and ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, and often effective interventions.

“There are differences between the evolution of those with bipolar 1 disorder compared with those with bipolar 2 disorder. There are also different ... alone or together with other drugs, such as ...

Acquisition includes CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of ...

We break it down into a three-part series, continuing here with Part II. When looking at the five open jobs on the market, it is hard to say the Jaguars don't have a significant advantage at the ...

Healthcare professionals may recommend tapering off antidepressants, like Lexapro, if you experience unwanted side effects, need to switch medications, or have reached the end of a short-term ...